Dr. Ron Boch

Vice President, Biotechnology and Industry Affairs, BIOTECanada

Dr. Ron Boch is the Vice President, Biotechnology and Industry Affairs with lead responsibility for BIOTECanada’s policy development. He brings a wide range of scientific, research and commercialization expertise in his work with emerging companies, vaccine manufacturers and global pharmaceutical companies, having worked for over 25 years with industry particularly regarding biopharmaceutical, biotechnology, and vaccine products. Dr. Boch serves advisory Boards including the Canadian Society for Pharmaceutical Sciences, the Drug Development and Innovation Centre, and the Academy of Translational Medicine Regulatory Advisory Council. He is a named inventor of over 60 US and international patent applications including nine different patent families. At QLT Inc., he contributed to the development of Visudyne used for photodynamic therapy of age-related macular degeneration, the leading cause of blindness in people over 60.

CLINICAL TRIALS ONTARIO

Clinical Trials Ontario is a leading organization in the clinical trials community dedicated to strengthening, promoting and capitalizing on Ontario’s competitive advantages for conducting high-quality clinical trials. We work collaboratively with industry, research institutes, patients and the public and other health innovation organizations to improve the clinical trials environment and attract investment to the province, while supporting the highest ethical and quality standards.